| Literature DB >> 25223877 |
Sara P Cuellar-Bermudez1, Iris Aguilar-Hernandez, Diana L Cardenas-Chavez, Nancy Ornelas-Soto, Miguel A Romero-Ogawa, Roberto Parra-Saldivar.
Abstract
The marked trend and consumers growing interest in natural and healthy products have forced researches and industry to develop novel products with functional ingredients. Microalgae have been recognized as source of functional ingredients with positive health effects since these microorganisms produce polyunsaturated fatty acids, polysaccharides, natural pigments, essential minerals, vitamins, enzymes and bioactive peptides. For this reason, the manuscript reviews two of the main high-value metabolites which can be obtained from microalgae: pigments and essential lipids. Therefore, the extraction and purification methods for polyunsaturated fatty acids, astaxanthin, phycoerythrin and phycocyanin are described. Also, the effect that environmental growth conditions have in the production of these metabolites is described. This review summarizes the existing methods to extract and purify such metabolites in order to develop a feasible and sustainable algae industry.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25223877 PMCID: PMC4353334 DOI: 10.1111/1751-7915.12167
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Microalgae species of high-value compounds extraction and applications (Pulz and Gross, 2004; Spolaore et al., 2006; Casal et al., 2011; Guedes et al., 2011; Batista et al., 2013; Borowitzka, 2013; Sørensen et al., 2013)
| Species | Product | Application areas |
|---|---|---|
| Biomass, pigments | Health food, food supplement | |
| Lutein, β-carotene | Pharmaceuticals, nutrition | |
| Canthaxanthin, astaxanthin, β-carotene | Pharmaceuticals, nutrition, cosmetics | |
| Docosahexaenoic acid | Pharmaceuticals, nutrition | |
| Fatty acids | Pharmaceuticals, nutrition | |
| Carotenoids, β-carotene | Health food, food supplement, feed | |
| Phycocyanin | Pharmaceuticals, nutrition | |
| Carotenoids, astaxanthin, cantaxanthin, lutein | Health food, pharmaceuticals, feed additives | |
| Fatty acids, carotenoids, fucoxanthin | Pharmaceuticals, nutrition, cosmetics, animal nutrition | |
| Immune modulators | Pharmaceuticals, nutrition | |
| Lutein | Pharmaceuticals, nutrition | |
| Eicosapentaenoic acid | Pharmaceuticals, nutrition | |
| Fatty acids | Pharmaceuticals, cosmetics, baby food | |
| Arachidonic acid | Nutritional supplement | |
| Lipids, eicosapentaenoic acid, fatty acids | Nutrition, fuel production | |
| Arachidonic acid, polysaccharides | Pharmaceuticals, cosmetics, nutrition | |
| Lutein, β-carotene | Pharmaceuticals, nutrition, cosmetics | |
| Docosahexaenoic acid | Pharmaceuticals, nutrition | |
| Phycocyanin, γ-Linolenic acid, biomass protein | Health food, cosmetics | |
| Docosahexaenoic acid | Pharmaceuticals, nutrition |
Commercialization price of some high value compounds from algae
| Product | Price (€) Spolaore | Price (€) Brennan and Owende, | Price (€) Markou and Nerantzis, | Price (€) Borowitzka, |
|---|---|---|---|---|
| Phycobiliproteins | — | 11–50 mg−1 | — | |
| B-phycoerythrin | 105 mg−1 | — | 0.036 mg−1 | |
| C-phycocyanin | 360–72 460 Kg−1 | |||
| β-Carotene | — | 215–2150 Kg−1 | 218–510 Kg−1 | |
| Astaxanthin | — | 7150 Kg−1 | 1,450–5075 Kg−1 | |
| DHA oil/Omega-3 | — | 0.043 Kg−1 | 0.63–2.78 Kg−1 | 78–116 Kg−1 |
Price expressed in USD by the authors. Conversion factor of 1.38.
Global companies based in developing process and commercialization of high-value compounds from algae
| Company name | Location | Company name | Location |
|---|---|---|---|
| Algae. Tec | Australia | AlgaFuel, S.A (A4F) | Portugal |
| Solarvest BioEnergy | Canada | Necton | Portugal |
| Canadian Pacific Algae | Canada | Green Sea Bio Systems s.l. | Spain |
| Solarium Biotechnology S.A. | Chile | AlgaEnergy | Spain |
| BlueBio | China | Fitoplancton Marino | Spain |
| EcoFuel Laboratories | Czech Republic | Simris | Sweden |
| Aleor | France | Taiwan Chlorella Manufacturing Company | Taiwan |
| Fermentalg | France | Vedan | Taiwan |
| Roquette | France | AlgaeLink N.V | The Netherlands |
| Alpa Biotech | France | AlgaeBiotech | The Netherlands |
| IBV Biotech IGV GmbH | Germany | LGem | The Netherlands |
| Subitec | Germany | Solazyme, Inc. | USA |
| Algomed | Germany | Aurora Algae | USA |
| BlueBioTech | Germany | Solix Biosystems | USA |
| Phytolutions | Germany | Synthetic Genomics | USA |
| Algae Health | Ireland | Cellena | USA |
| Seambiotic | Israel | Cyanotech | USA |
| Algatechnologies | Israel | Algaeon | USA |
| UniVerve Biofuel | Israel | Alltech Algae | USA |
| Parry Nutraceuticals | India | Green Star Products, Inc | USA |
| Sunchlorella | Japan | Bionavitas | USA |
| Fuji Chemicals | Japan | Heliae | USA |
| DAESANG | Korea | Kuehnle Agro Systems | USA |
| Algaetech International | Malaysia | Photon8 | USA |
| June Pharmaceutical | Malaysia | Ternion BioIndustries | USA |
| Tecnología Ambiental BIOMEX | Mexico | Algae to Omega Holdings | USA |
| Algae Technology Solutions | Mexico | Sapphire Energy | USA |
| Aquaflow Binomics | New Zealand | Algenol | USA |
| Photonz | New Zealand |
PUFAs extracted in different microalgae species
| Species | Product | Yield | Extraction/Purification method | Reference |
|---|---|---|---|---|
| Total lipids | 13.2% DW | Chloroform–methanol 1:1 (%v/v) | Ryckebosch and colleagues ( | |
| 19.9% DW | ||||
| ALA | 661 mg/100 g | Acid digestion of biomass with 4 N HCl. | Batista and colleagues ( | |
| EPA | 19 mg/100 g | |||
| DHA | 16 mg/100 g | Soxhlet method with petroleum ether for 6 h | ||
| GLA | 112 mg/100 g | |||
| ALA | 3665 mg/100 g | |||
| EPA | 39 mg/100 g | |||
| DHA | 80 mg/100 g | |||
| GLA | 23 mg/100 g | |||
| DHA | 99.2% purity | Purification by saponification, winterization and urea complexation | Mendes and colleagues ( | |
| ALA | 14 mg/100 g | Acid digestion of biomass with 4 N HCl. | Batista and colleagues ( | |
| EPA | 3212 mg/100 g | |||
| DHA | 836 mg/100 g | Soxhlet method with petroleum ether for 6 h | ||
| GLA | 112 mg/100 g | |||
| ALA | 3981 mg/100 g | |||
| EPA | 579 mg/100 g | |||
| GLA | 472 mg/100 g | |||
| ALA | 421 mg/100 g | |||
| EPA | 4875 mg/100 g | |||
| DHA | 1156 mg/100 g | |||
| Total Lipids | 29.7% DW | Chloroform–methanol 1:1 (%v/v) | Ryckebosch and colleagues ( | |
| ALA | 40 mg/100 g | Acid digestion of biomass with 4 N HCl. Soxhlet method with petroleum ether for 6 h | Batista and colleagues ( | |
| GLA | 452 mg/100 g | |||
| Total Lipids | 34.4% DW | Chloroform–methanol 1:1 (%v/v) | Ryckebosch and colleagues ( | |
| EPA | 3.7 g/100 g DW | Dichloromethane-ethanol (1:1) | Ryckebosch and colleagues ( | |
| ARA | 9.1% DW | Methanol (10%DMSO) at 40°C for 5 min. | Bigogno and colleagues ( | |
| Diethyl ether, hexane and water 1:1:1 (v/v/v) | ||||
| EPA | 9.3% DW of total fatty acids (39%) | Chloroform–methanol 1:1 (%v/v) | Ryckebosch and colleagues ( | |
| EPA | 50.8% recovery, 97% purity | Purification by saponification and urea complexation | Guil-Guerrero and colleagues ( | |
| EPA | 10.41% of phospholipid fraction | Chloroform-methanol 2:1 (%v/v). Extract was washed with 0.88% w/v KCl to remove non-lipids | Makri and colleagues ( |
Figure 1Pathway for the biosynthesis of omega-3 LC-PUFA (Wen and Chen, 2003; Adarme-Vega et al., 2012; Ryckebosch et al., 2012).
Extraction of natural pigments in microalgae species
| Species | Product | Extraction/Purification method | Yield/Extraction efficiency | Reference |
|---|---|---|---|---|
| Astaxanthin | Solvent system with methanol (75%) and dichloromethane (25%). French Pressure Cell (110 MPa). Solution filtration (0.45 μm). Saponification in darkness (50 mg NaOH in 100 ml methanol). | 7.09 mg/g DW | Ma and Chen ( | |
| Astaxanthin | Acid digestion, HCL 2N, 70°C. Acetone extraction for 1 h | 87% efficiency | Sarada and colleagues ( | |
| Dodecane mixing for 48 h. Saponification with methanolic NaOH (0.02M). Sedimentation in darkness at 4°C, 12 h. | 85% efficiency | Kang and Sim ( | ||
| SC-CO2 at 55 MPa and 343°K. | 77.9% efficiency | Machmudah and colleagues ( | ||
| Hexane : acetone : ethyl alcohol (100:70:70 %v/v). | N/A | Domínguez-Bocanegra and colleagues ( | ||
| DMSO (55°C), vortex 30 s | N/A | Orosa and colleagues ( | ||
| SC-CO2 at at 20 MPa, 60°C, 2 ml of ethanol for 1 h of extraction time | 2.45 mg/g DW | Fujii ( | ||
| SC-CO2 at 20 MPa, 55°C and13% (w/w) ethanol for 120 min of extraction time. | 83% recovery | Reyes and colleagues ( | ||
| CO2 expanded ethanol (50% %w/w ethanol), 7 MPa, 45°C, 120 min of extraction time. | 124.2% recovery | |||
| Allophycocyanin | Incubation of sample for 2 h at 37°C, nitrogen cavitation cycles at 1500 psi for 10 min, centrifugation for 40 min at 18 000 rpm to remove cell debris. | 85.2–87.9% DW | Viskari and Colyer ( | |
| C-phycocyanin | ||||
| Phycoerythrin | ||||
| C-phycocyanin | Distilled water, activated carbon (1% w/v) and chitosan (0.01 g/L) for extraction. Ammonium sulfate (25%) was used for purification at 4°C, overnight. Precipitate was resuspended in 0.1 M PBS (pH 7.0) and tangential flow filtration system (30 kDa membrane pore) was used for pigment concentration. | 18% DW | Gantar and colleagues ( | |
| C-phycocyanin | 0.1 M PBS at pH of 6.8 and sonication at 28 KHz for extraction. Ultracentrifugation at 200 000 × g for purification | 90% purity | Furuki and colleagues ( | |
| Allophycocyanin C-phycocyanin | 100 mM phosphate buffer (pH 7.0) at a ratio of 1:100 (w/v) with continuous stirring at 300 rpm at room temperature for 4 h. | N/A | Chaiklahan and colleagues ( | |
| Phycoerythrin | Ammonium sulfate at 85% saturation. Purification by three consecutive chromatographic steps; hydroxyapatite column eluted with 100 mM phosphate buffer (pH 7) 0.2 M of NaCl, a Q-sepharose column and a Sephacryl S-200 HR resin. | A565/A280 = 17.3 | Pumas and colleagues ( | |
| 1.36% yield | ||||
| Phycoerythrin | Homogenization in 1 M acetic acid–sodium acetate buffer sonication for 10 min, ammonium sulfate precipitation (65% saturation) and dialysis, followed by ion exchange chromatography. | 32.7% DW | Bermejo Román and colleagues ( | |
| Cell maceration with glass beads, simultaneous recovery and purification with a PEG-phosphate ATPS. | A565/A280 = 2.8 | Benavides and Rito-Palomares ( | ||
| 76% recovery | ||||
| Phycoerythrin | Freeze-thaw cycles (− 30oC and 4oC) in 1 M Tris Cl Buffer, two-step ammonium sulfate precipitation at 20% and 70% saturation and purification by gel permeation chromatography with a Sephadex G-150 matrix. | A565/A280 = 3.9 | Parmar and colleagues ( | |
| 62.6% yield |
DW, dry weight.
Figure 2Biosynthesis pathway for phycobilins formation from Biliverdin (Brown et al., 1984; Lamparter et al., 2002). Reactions are: (i) biliverdin 15,16-reductase, (ii) bilin 2,3-reductase (iii) phycobilin (15,16-metylene-to-182,183-ethyl) isomerase.
Figure 3Biosynthethic pathway for the formation of astaxanthin in the microalgae H. pluvialis (Lemoine and Schoefs, 2010). Enzymes are 1: 4,4′- ketolase, 2: 4,4′-ketolase, 3: 3′3-Hydroxylase, 4: 3′3-Hydroxylase.